VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,939,250 | -29.4% | 7,130,917 | +3.4% | 0.00% | -33.3% |
| Q2 2023 | $111,766,701 | +229.0% | 6,894,923 | +237.9% | 0.00% | +200.0% |
| Q1 2023 | $33,970,629 | +168.5% | 2,040,278 | +51.6% | 0.00% | – |
| Q4 2022 | $12,652,523 | +217.3% | 1,346,013 | -8.2% | 0.00% | – |
| Q3 2022 | $3,987,000 | -3.3% | 1,466,256 | +2.7% | 0.00% | – |
| Q2 2022 | $4,124,000 | -73.3% | 1,427,221 | -72.3% | 0.00% | – |
| Q1 2022 | $15,442,000 | -34.4% | 5,147,461 | +0.5% | 0.00% | -100.0% |
| Q4 2021 | $23,549,000 | -26.8% | 5,119,490 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $32,161,000 | +2.5% | 5,121,133 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $31,388,000 | -6.8% | 5,240,050 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $33,693,000 | +12.6% | 5,327,110 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $29,931,000 | +9.2% | 5,316,337 | +12.9% | 0.00% | 0.0% |
| Q3 2020 | $27,416,000 | -20.6% | 4,710,752 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $34,519,000 | +55.4% | 4,787,745 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $22,218,000 | -41.1% | 4,747,693 | +0.9% | 0.00% | 0.0% |
| Q4 2019 | $37,752,000 | +22.1% | 4,707,261 | +4.7% | 0.00% | 0.0% |
| Q3 2019 | $30,931,000 | -15.2% | 4,495,717 | +2.3% | 0.00% | -50.0% |
| Q2 2019 | $36,482,000 | -10.8% | 4,395,385 | +6.8% | 0.00% | 0.0% |
| Q1 2019 | $40,896,000 | +30.4% | 4,114,466 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $31,361,000 | -46.3% | 4,099,406 | +22.4% | 0.00% | -33.3% |
| Q3 2018 | $58,355,000 | +109.2% | 3,349,901 | +14.0% | 0.00% | +200.0% |
| Q2 2018 | $27,888,000 | +1595.3% | 2,938,645 | +681.0% | 0.00% | – |
| Q1 2018 | $1,645,000 | +54733.3% | 376,289 | +53426.2% | 0.00% | – |
| Q4 2017 | $3,000 | +200.0% | 703 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 703 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 703 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |